NeuraCeq obtains E.U. approval for PET imaging of beta-amyloid neuritic plaque density Feb. 25, 2014 No Comments
Vanda's Hetlioz becomes first FDA-approved treatment for non-24-hour sleep-wake disorder Feb. 3, 2014 No Comments
RSS